共同 の 意思決定 と 心血管 健康: アメリカ 心臓 協会 の 科学 的 な 声明
Circulation
|August 14, 2023
まとめ
心血管疾患のケアにおける 意思決定の共有は 結果を改善し 公平性を促進します 戦略には,臨床医教育,意思決定支援,そして実践の障壁を克服するためのチーム参加が含まれています.
科学分野:
- 心血管医学
- 医療サービス研究
- 健康に関する公平性
背景:
- 共同意思決定 (SDM) は,患者中心の心臓血管ケアにおいて,健康成果と公平性を改善することを目的としています.
- ガイドラインで承認されているが,患者,臨床医,システムレベルの障壁のために,心臓血管の実践におけるSDMの実施は最適ではない.
- 正式なモデルと心血管ケアにおけるSDMの評価はまだ開発中です.
研究 の 目的:
- SDMが心血管疾患に及ぼす影響に関する証拠を検証する.
- 保健の平等の推進力としてSDMの可能性を強調する.
- 心血管のケアにおけるSDMを促進するための多層の解決策を特定する.
主な方法:
- この科学的記述は,心臓血管の健康に関する共有意思決定に関する現在の文献をまとめています.
- 臨床医の研修や患者の意思決定支援を含む効果的な実施戦略を考察しています.
- この見直しでは,課題を解決し,より広範な採用のための多層の解決策を提案しています.
主要な成果:
- SDMが心血管疾患に ポジティブな影響を与えているという証拠はありますが 研究の成果は増え続けています
- SDMは患者の価値観とニーズを中心に 健康の平等を大幅に推進する可能性を秘めています
- 効果的な戦略には,臨床医のコミュニケーションスキル,多学科チーム,意思決定コーチ,患者へのアクセス可能な意思決定支援が含まれます.
結論:
- 高品質で価値に基づいた心臓血管疾患のケアと健康の平等を達成するために,共有意思決定の実施は不可欠です.
- SDMの採用を成功させるには 政策,補償,システムインフラ,臨床医の研修,患者への関与が不可欠です
- SDMにおける患者と臨床医を全面的に支援し,最終的には心血管疾患の成果と公平性を改善するために,多層の解決策が必要です.
さらに関連する動画
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
3.9K
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
7.6K
関連する概念動画
Coronary Artery Disease IV: Preventive Measures
24
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Assessment of the Cardiovascular System I: Subjective Data
366
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
366
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Atherosclerosis IV: Nursing Management
23
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
23
